ALBANY, N.Y., April 1, 2021 /PRNewswire/ — The widespread utilization of cerebral somatic oximeters in both non-hemostasis and hemostasis applications is likely to propel the growth of the global cerebral somatic oximeters market in the years to come. In addition to that, the increasing utilisation of cerebral somatic oximeters by various end users such as ambulatory surgical centres, hospitals, and clinics is estimated to bode well for the said market in the years to come. Less oxygen supply to the brain induces neurological disorders and brain damage conditions including hypoxic-ischemic encephalopathy (HIE). As a result, demand for cerebral oximeters is expected to rise as the incidence of cerebral hypoxia increases.
The World Health Organization (WHO) estimates that 15 million people had a stroke per year, with 5 million fatalities every year. As a result, the demand for cerebral somatic oximeters is growing in order to monitor these alarming death rates. In the end, its usage to reduce the death rate is likely to work in favour of the global cerebral somatic oximeters market over the assessment timeframe. Besides, t he danger of HIE amongst children could propel the demand for cerebral somatic oximeters to new heights. As per world health organisation (WHO), HIE is the world’s fifth most common cause of infants’ death. The need for better HIE management can therefore lead to development of the global cerebral somatic oximeters market.
Request for…
